Table 3 Primary outcome variable: the frequency of success and failure outcomes by group
Group | Outcome | Total | P value | |
|---|---|---|---|---|
Success | Failure (Withdrawn from study) | |||
Robenacoxib | 89 (76.72%) | 27 (23.28%) | 116 | 0.019 |
Placebo | 74 (64.35%) | 41 (35.65%) | 115 | |
Total | 163 | 68 | 231 | Â |